CA Patent

CA3110997A1 — Oral film compositions and dosage forms having precise active dissolution profiles

Assigned to Aquestive Therapeutics Inc · Expires 2020-03-12 · 6y expired

What this patent protects

An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also …

USPTO Abstract

An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example., epilepsy and seizures, by administering the oral film disclosed herein.

Drugs covered by this patent

Patent Metadata

Patent number
CA3110997A1
Jurisdiction
CA
Classification
—
Expires
2020-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Aquestive Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.